Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1600 of 2026 entries
View as:

A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable

Phase: N/A Priority: Normal
NCT ID: NCT01739218 Org: User:
Start: 02/01/13 End: 08/17/16 Due: 08/17/17

A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01873508 Org: User:
Start: 06/30/13 End: 08/31/13 Due: 08/31/14

A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Phase: N/A Priority: Normal
NCT ID: NCT00801255 Org: User:
Start: 11/30/08 End: 03/31/10 Due: 03/31/11

A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies

Phase: N/A Priority: Normal
NCT ID: NCT00962975 Org: User:
Start: 09/30/09 End: 05/31/13 Due: 05/31/14

A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.

Phase: N/A Priority: Normal
NCT ID: NCT00773461 Org: User:
Start: 10/31/08 End: 07/22/10 Due: 07/22/11

A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)

Phase: N/A Priority: Normal
NCT ID: NCT02409355 Org: User:
Start: 05/07/15 End: 12/07/17 Due: 12/07/18

A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.

Phase: N/A Priority: Normal
NCT ID: NCT00440063 Org: User:
Start: - End: - Due: -

A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)

Phase: N/A Priority: Normal
NCT ID: NCT01272908 Org: User:
Start: 07/18/06 End: 03/12/09 Due: 03/12/10

A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04308785 Org: User:
Start: 12/01/21 End: 07/25/23 Due: 07/25/24

A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

Phase: N/A Priority: Normal
NCT ID: NCT04712643 Org: User:
Start: 03/12/21 End: 02/01/29 Due: 02/01/30

A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs

Phase: N/A Priority: Normal
NCT ID: NCT01878318 Org: User:
Start: 06/30/13 End: 06/30/15 Due: 06/30/16

Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03330990 Org: User:
Start: 11/14/17 End: 07/11/18 Due: 07/11/19

A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02545283 Org: User:
Start: 12/30/15 End: 04/24/20 Due: 04/24/21

A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe

Phase: N/A Priority: Normal
NCT ID: NCT01344863 Org: User:
Start: 04/30/11 End: 01/31/12 Due: 01/31/13

A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01773408 Org: User:
Start: 02/28/13 End: 06/30/16 Due: 06/30/17

An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01442155 Org: User:
Start: 10/31/11 End: 04/30/15 Due: 04/30/16

Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02605915 Org: User:
Start: 12/31/15 End: 11/13/19 Due: 11/13/20

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT02537691 Org: User:
Start: 08/28/15 End: 07/10/17 Due: 07/10/18

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03629184 Org: User:
Start: 11/20/18 End: 04/03/19 Due: 04/03/20

Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00496457 Org: User:
Start: 05/31/07 End: 12/31/08 Due: 12/31/09

A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02581423 Org: User:
Start: 08/31/05 End: 03/31/07 Due: 03/31/08

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00927082 Org: User:
Start: 04/30/09 End: 11/30/14 Due: 11/30/15

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.

Phase: N/A Priority: Normal
NCT ID: NCT00377481 Org: User:
Start: 09/30/06 End: 06/30/07 Due: 06/30/08

A Study of RG1662 in Individuals With Down Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01436955 Org: User:
Start: 11/30/11 End: 09/30/13 Due: 09/30/14

A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00545714 Org: User:
Start: 11/21/07 End: 05/20/16 Due: 05/20/17